Ultrasonic Technologies Ltd and Ultrasonic Technologies Inc.
Ultrasonic Technologies Ltd are company at the forefront of advancing for both diagnostic imaging and drug delivery. These companies are contributing significantly to the evolution of ultrasound as a theranostic tool, focusing on improving the precision and efficiency of ultrasound technologies for clinical applications.
Introduction to Ultrasound Technologies
Ultrasound technology has become a vital tool in both diagnostic imaging and drug delivery, offering promising theranostic applications. The advent of high frame-rate ultrasound has significantly enhanced functional and molecular imaging. Key developments, such as shear wave elastography, high-frequency ultrasound, contrast imaging, and super-resolution blood flow imaging, have expanded the scope of ultrasound in clinical practice.
Therapeutic Potential of Ultrasound and Microbubbles
Ultrasound, combined with microbubbles (MBs) and phase-change droplets, has proven therapeutic potential. MBs, which are used as ultrasound contrast agents, can load therapeutic agents and release them locally when exposed to ultrasound, improving drug delivery. The cavitation effect of MBs not only facilitates targeted drug release but also enhances tissue permeability, making it possible to overcome barriers like the blood-brain barrier (BBB).
Ultrasound Contrast Agents: Microbubbles and Phase-Change Droplets
Microbubbles provide contrast for ultrasound imaging and serve as vehicles for drug delivery. The cavitation of MBs triggered by ultrasound enhances the delivery of therapeutics, while phase-change droplets can vaporize into bubbles under ultrasound, further boosting contrast and therapeutic effects.
Advancements in Imaging and Drug Delivery
Recent innovations in ultrasound technology, such as ultrafast ultrasound imaging and advanced contrast agents, have revolutionized both diagnostic imaging and drug delivery. Ultrasound’s ability to deliver real-time, non-invasive imaging with minimal risks.
Conclusion
Ultrasonic technologies have transformed from purely diagnostic tools into powerful theranostic agents. Ongoing research and development in ultrasound imaging and drug delivery promise to expand its clinical applications,
